8: Advances in Multiple Sclerosis - Hughes Flashcards
multiple sclerosis only gives you…
UMN findings
describe MS
- episodes of focal disorder of the CNS
- demyelinating AND axonal disease
- white matter predominant but also affects grey matter
- autoimmune disease
which virus has been implicated in MS?
EBV
titers present in almost all MS pts and levels are increased during acute MS attacks
I have MS. Are my kids going to get it?
1/40 chance
concordance rate of 30% in monozygotic twins
immunology of MS
- predominantly aberrant Tcell immune response ( B cells and macrophages also play role)
- dysfunction in BBB allowing the activated cells to cross into the CNS attacking myelin
85% of MS patients start with…
relapsing-remitting MS
some start with primary progressive
secondary progressive from the relapsing remitting
poor prognostic indicators for MS
- male
- older age at onset
- posterior fossa symptoms at onset
- African American
- Significant residual disability from first attack
spots in the corpus callosum =
highly suspicious of MS (demyelinating)
what in a CSF exam would indicated MS?
- presence of oligoclonal IgG bands
- elevated IgG synthesis rate
- nonspecific elevation in prtn
- pleocytosis of typically less than 50 wbc and only very rarely above 100
VER visual evoked response
MS has a slower response
most helpful evoked potential test
describe neuromyelitis optica aka Devic’s disease
- demyelinating disease of CNS
- purely B cell driven disease
- associated with aquaporin 4
- blind and quadraplegic with intact brain
describe Disseminated encephalomyelitis
- pediatric greater than adult
- febrile illness
- grey and white matter
- monophasic (one attack- cognitive issues, seizure,
only FDA approved drug for improved walking speed in MS patients
fampridine
K channel blocker - improves conductivity in demyelinated nerves
what supplements might a MS be taking?
- Vit D ( only recommended supplement - impacts immune system, also good for osteoporosis)
immune modulators used in treatment of MS
- beta interferon
- glatiramer acetate
- mitozantrone
- natalizumab, alemtuzumab
- fingolimod